(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

A

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

A

ST13

US500000098379932

Class

5, 42

Filing

98379932

Registration

7650815

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

16

Latest update

01/14/2025

Trademark type

Combined

Nice classes

5, 42

Filing date

01/29/2024

Registration date

01/14/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/14/2025

Last transaction

01/14/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

05/09/2024

First use in commerce

05/09/2024

Drawing code

3

Owner type

16

Owner location

Parsippany, NJ, US

Examiner

HOPKINS II, DEAN

Law office

N50

Current location

GENERIC WEB UPDATE

Mark description

The mark consists of a stylized letter "A" with the outside lines of the letter in blue with a 3D appearance and a long green swoosh and a short green swoosh going from the base of the left outside line and the long swoosh going through and beyond the middle of the right outside blue line and the short swoosh stopping at the middle of the right outside blue line.

Holders and representatives

Holders

Avyxa Pharma LLC

Representatives

R. Scott Keller Warner Norcross + Judd LLP

Technical classification

Nice Classes

Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment and prevention of oncological disorders

Class 42

Pharmaceutical drug development services; Pharmaceutical research and development

Publications

History of USPTO decisions and trademark events.

16 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/14/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

01/14/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/26/2024

PUBO

PUBLISHED FOR OPPOSITION

11/26/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/20/2024

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

09/18/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/04/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/16/2024

IUAA

USE AMENDMENT ACCEPTED

08/16/2024

DOCK

ASSIGNED TO EXAMINER

08/08/2024

AUPC

AMENDMENT TO USE PROCESSING COMPLETE

06/04/2024

IUAF

USE AMENDMENT FILED

06/04/2024

EAAU

TEAS AMENDMENT OF USE RECEIVED

06/04/2024

MDSM

NOTICE OF DESIGN SEARCH CODE E-MAILED

05/26/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/26/2024

NWAP

NEW APPLICATION ENTERED

01/29/2024

Continuous trademark protection

Get notified about every new filing that threatens A or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.